Clinical trial
Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure
NCT03437226 is registered in ClinicalTrials.gov with Dr. Gerhard Pölzl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repetitive Levosimendan Infusion for Patients With Advanced Chronic Heart Failure
- Lead sponsor
- Dr. Gerhard Pölzl
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 8, 2018
- Completion date
- December 31, 2019
- Enrollment
- 264 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.